Trade

Ngl Fine Chem share price

High risk
  • 45%Low risk
  • 45%Moderate risk
  • 45%Balanced risk
  • 45%High risk
  • 45%Extreme risk
  • 1,326.15(-2.85%)
    December 12, 2025 15:26:37 PM IST
    • NSE
    • BSE
  • Vol : 3.84 K (NSE + BSE)
    Last 20 day avg : 2.72 K

Ngl Fine Chem is trading -2.85% lower at Rs 1,326.15 as compared to its last closing price. Ngl Fine Chem has been trading in the price range of 1,331.65 & 1,305.00. Ngl Fine Chem has given -26.75% in this year & 2.09% in the last 5 days. Ngl Fine Chem has TTM P/E ratio 41.42 as compared to the sector P/E of 28.49.The company posted a net profit of 9.63 Crores in its last quarter.Listed peers of Ngl Fine Chem include Dr Reddy's Laboratories (0.51%), Cipla (0.20%), Torrent Pharmaceuticals (-0.56%).The Mutual Fund holding in Ngl Fine Chem was at -% in . The MF holding has - from the last quarter. The FII holding in Ngl Fine Chem was at 0.05% in 31 Dec 2024. The FII holding has increased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on Dec 15, 2025, 03:16 AM UTC

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    1.73
    High volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.27
    Higher than industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.13
    Lower than industry
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -1.56
    Indicates undervaluation
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    -
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    -
Price range
Day Range
Lowest
1,305.00
Highest
1,331.65
52 week range
Lowest
962.70
Highest
2,161.00
Ngl Fine Chem Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Dr Reddy's Laboratories
Bullish
1,279.500.511,06,797.3018.803.170.632.34
Cipla
Neutral
1,515.150.201,22,555.0523.333.940.850.81
Torrent Pharmaceuticals
Bullish
3,780.00-0.561,28,240.2866.6416.920.8417.62
Sun Pharmaceutical Industries
Bullish
1,794.50-0.694,30,502.1737.946.040.880.50
Divi's Laboratories
Bullish
6,414.50-0.271,70,614.0078.2711.470.460.01
Mutual Fund Ownership
View all
Bandhan BSE Healthcare Index Fund Regular Growth
NA
  • Amount Invested (Cr.) 0.01
  • % of AUM 0.01
Ngl Fine Chem Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2025-11-12Quarterly Results
2025-08-01Quarterly Results
2025-05-22Audited Results & Final Dividend
2025-02-07Quarterly Results
2024-11-08Quarterly Results
About the company Ngl Fine Chem
  • IndustryBiotechnology & Drugs
  • ISININE887E01022
  • BSE Code524774
  • NSE CodeNGLFINE
NGL Fine-Chem Limited is an India-based company, which is a manufacturer of pharmaceuticals and intermediates for use in veterinary and human health. The Company caters to various global companies to custom manufacture pharmaceuticals. Its products include APIs Animal Health, APIs Human Health, Intermediates and Specialty Chemicals and Finished Dosage Form. The APIs Animal Health products include Homidium Chloride, Nitroxynil, Clorsulon, Parvaquone, Buparvaquone, Isometamidium Chloride Hydrochloride, Toldimfos Sodium, Butaphosphan, Imidocarb Dipropionate, Triclabendazole, Rafoxanide, Diminazene Aceturate, S-Methoprene, Carprofen and others. The APIs Human Health products include Nitazoxanide and Atovaquone. The Intermediates and Specialty Chemicals product includes 1,4,7-Trimethyl-1,4,7-Triazacylononane and N-Ethyl Glucamine. The Finished Dosage Form products include Diminazene Aceturate Granules and Homidium Chloride Tablets. It has manufacturing plants located around Mumbai.
  • Management Info
  • Rajesh LawandeChief Financial Officer, Whole Time Director
  • Pallavi PednekarCompliance Officer, Company Secretary
  • Rahul NachaneManaging Director, Director
Ngl Fine Chem Share Price FAQs

Ngl Fine Chem is trading at 1326.15 as on Fri Dec 12 2025 09:56:37. This is -2.85% lower as compared to its previous closing price of 1365.00.

The market capitalization of Ngl Fine Chem is 811.51 Cr as on Fri Dec 12 2025 09:56:37.

The 52 wk high for Ngl Fine Chem is 2161.00 whereas the 52 wk low is 962.70

Ngl Fine Chem can be analyzed on the following key metrics -

  • TTM P/E: 41.42
  • Sector P/E: 28.49
  • Dividend Yield: 0.13%
  • D/E ratio: 0.34

Ngl Fine Chem reported a net profit of 21.12 Cr in 2025.